Biohaven Ltd. BHVN
12.99
(0.20)
(1.52%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow BHVN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.30 | 2.75 | 6.68 | 4.28 | |
Current Ratio |
2.86 | 3.18 | 7.41 | 4.73 | |
Net Debt/EBITDA |
(0.05) | 0.57 | 0.83 | 0.07 | |
Debt/Assets |
65.57% | 52.92% | 51.87% | 69.99% | |
Debt/Equity |
(15.63) | 4.59 | 1.87 | 21.23 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.90 | 1.15 | 0.62 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.20) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.05 | 0.04 | 0.04 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.38) | (1.21) | (1.02) | (0.56) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.38) | (1.21) | (1.02) | (0.57) | |
Cash per Share |
2.46 | 2.97 | 2.36 | 1.78 | |
Shareholders Equity per Share |
(0.16) | 0.48 | 0.88 | 0.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.16) | 0.48 | 0.88 | 0.08 | |
Free Cash Flow |
(145.73) | (130.67) | (149.92) | (85.55) | |
Working Capital |
210.59 | 252.40 | 333.57 | 233.90 | |
Capital Expenditures |
(0.01) | (0.01) | — | (0.45) | |
Net Current Asset Value |
(102.67) | (31.05) | 48.74 | (61.96) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
18.62 | 14.84 | 14.78 | 15.87 | |
Average Assets |
459.82 | 533.28 | 462.68 | 460.58 | |
Average Common Equity |
149.42 | 237.75 | 194.50 | 73.40 |
Columns are period end dates